…
Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. Our company was originally founded in 1985. We are organized as an umbrella partnership REIT. We hold substantially all our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and continuing care retirement community real estate. Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the CCRC segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) an interest in an unconsolidated joint venture that owns 19 senior housing assets, (ii) loans receivable, and (iii) a preferred equity investment. These non-reportable segments have been presented on a combined basis herein. At September 30, 2025, our portfolio of investments, including properties in certain of our unconsolidated joint ventures, consisted of interests in 703 properties: (i) Outpatient medical " 530 properties; (ii) Lab " 139 properties; (iii) CCRC " 15 properties; and (iv) Other non-reportable " 19 properties. Healthpeak Properties, Inc. was incorporated in 1985 in Maryland, USA.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Healthpeak Properties is a REIT that owns and operates medical office and life-science properties in major U.S. markets. Long-term growth may be driven by structural demand for lab and outpatient space, a focused development pipeline in biotech hubs, and portfolio allocation to higher-growth healthcare sectors supporting rental cash flows.
Key risks include interest-rate sensitivity and leverage, tenant concentration and biotech cyclicality, and development or regional oversupply that could weaken occupancy and cash flow.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 110.31M | 271.65M | 325.14M | 110.04M | 86.78M |
| Minority interest | -29.68M | -24.16M | -28.57M | -5.67M | 2.21M |
| Net income | 71.35M | 243.14M | 306.01M | 37.80M | 25.40M |
| Selling general administrative | 90.42M | 97.16M | 95.13M | 40.21M | 37.76M |
| Selling and marketing expenses | - | - | 8.00M | - | - |
| Gross profit | 634.55M | 1625.59M | 1278.94M | 355.54M | 320.29M |
| Reconciled depreciation | 1022.12M | 1057.20M | 740.51M | 189.64M | 157.87M |
| Ebit | 544.13M | 553.60M | 515.27M | 124.89M | 123.09M |
| Ebitda | 1603.00M | 1610.80M | 1265.17M | 314.54M | 280.96M |
| Depreciation and amortization | 1058.87M | 1057.20M | 749.90M | 189.64M | 157.87M |
| Non operating income net other | - | - | - | 56.59M | 22.59M |
| Operating income | 544.13M | 471.22M | 433.91M | 124.89M | 123.09M |
| Other operating expenses | 2278.38M | 2229.23M | 1747.09M | 400.95M | 333.04M |
| Interest expense | 305.18M | 280.43M | 200.33M | 72.23M | 60.14M |
| Tax provision | 9.28M | 4.35M | 1.57M | - | - |
| Interest income | 305.18M | 280.43M | 200.33M | 0.79M | 1.57M |
| Net interest income | -305.18M | -280.43M | -196.96M | -72.23M | -60.14M |
| Extraordinary items | - | 0.00M | 0.00M | - | - |
| Non recurring | - | - | - | 72.23M | 60.48M |
| Income tax expense | 9.28M | 4.35M | -9.62M | 72.23M | 61.38M |
| Total revenue | 2822.51M | 2700.45M | 2181.00M | 526.63M | 457.70M |
| Total operating expenses | 90.42M | 1154.37M | 845.03M | 229.85M | 195.63M |
| Cost of revenue | 2187.96M | 1074.86M | 902.06M | 171.10M | 137.41M |
| Total other income expense net | -433.82M | -199.57M | -108.77M | -14.86M | -36.31M |
| Net income from continuing ops | 101.03M | 267.30M | 269.29M | 110.04M | 64.19M |
| Net income applicable to common shares | 70.51M | 242.38M | 304.28M | 104.37M | 83.95M |
| Preferred stock and other adjustments | - | - | - | - | 0.01M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 20336.02M | 19938.26M | 15698.85M | 5096.88M | 5182.71M |
| Intangible assets | 654.52M | 817.25M | 314.16M | 505.33M | 498.22M |
| Other current assets | -148.57M | 72.33M | 169.37M | 12.57M | 12.65M |
| Total liab | 12033.57M | 10880.63M | 8773.98M | 2099.77M | 2188.59M |
| Total stockholder equity | 7500.09M | 8401.28M | 6350.45M | 2869.72M | 2836.31M |
| Deferred long term liab | - | - | - | 13.23M | 11.63M |
| Other current liab | -718.51M | 427.86M | 417.67M | 147.87M | 143.50M |
| Common stock | 695.04M | 699.49M | 547.16M | 2.33M | 2.25M |
| Capital stock | 695.04M | 699.49M | 547.16M | 2.33M | 2.25M |
| Retained earnings | -5952.92M | -5174.28M | -1061.29M | -881.67M | -776.00M |
| Other liab | - | - | - | 59.98M | 21.57M |
| Good will | 68.53M | 68.53M | 18.00M | - | - |
| Other assets | 18016.05M | 187.42M | -21.36M | 4169.90M | 4486.98M |
| Cash | 537.70M | 119.82M | 117.64M | 7.73M | 9.88M |
| Cash and equivalents | 467.46M | 119.82M | 117.64M | 7.73M | 9.88M |
| Total current liabilities | 985.31M | 875.34M | 1377.92M | 340.59M | 417.79M |
| Current deferred revenue | 985.31M | - | -16.95M | - | - |
| Net debt | 9902.71M | 8903.45M | 6965.41M | 1915.40M | 2007.00M |
| Short term debt | 995.00M | 171.51M | 720.00M | 188.33M | 267.64M |
| Short long term debt | 1078.85M | 150.00M | 720.00M | 188.33M | 267.64M |
| Short long term debt total | 10440.41M | 9023.27M | 7083.04M | 1923.13M | 2016.88M |
| Other stockholder equity | 12767.91M | 12847.25M | 5783.92M | 3743.88M | 3610.95M |
| Property plant equipment | 16511.29M | 16255.58M | 13268.52M | 4748.15M | 4348.48M |
| Total current assets | 1073.48M | 986.14M | 561.28M | 124.21M | 134.63M |
| Long term investments | 802.60M | 936.81M | 782.85M | 77.72M | 5036.30M |
| Net tangible assets | - | - | - | 2872.98M | 2338.09M |
| Short term investments | - | - | 21.36M | 77.72M | 69.79M |
| Net receivables | 684.35M | 794.00M | 274.27M | 116.48M | 122.79M |
| Long term debt | 8769.04M | 8566.05M | 6156.30M | 1818.12M | 1911.92M |
| Inventory | - | - | 612.67M | -12.57M | -10.69M |
| Accounts payable | 718.51M | 275.97M | 240.26M | 4.39M | 6.65M |
| Noncontrolling interest in consolidated entity | - | - | - | 124.13M | 150.72M |
| Accumulated other comprehensive income | -9.94M | 28.82M | 19.37M | 5.18M | -0.89M |
| Common stock total equity | - | - | - | 2.33M | 2.25M |
| Retained earnings total equity | - | - | - | -881.67M | -776.00M |
| Non currrent assets other | -802.60M | 16773.87M | 13800.41M | 4158.40M | 131.58M |
| Non current assets total | 1246.49M | 18952.11M | 15137.57M | 4972.67M | 5048.08M |
| Capital lease obligations | 296.26M | 307.22M | 206.74M | 105.01M | 104.96M |
| Long term debt total | 9847.89M | 7908.62M | 6869.27M | 1818.12M | 1911.92M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -113.80M | -659.32M | -104.57M | -650.30M |
| Change to liabilities | - | - | - | -0.80M | -1.07M |
| Total cashflows from investing activities | -1050.05M | -113.80M | -576.75M | -38.47M | -603.22M |
| Net borrowings | 1108.68M | 153.22M | 378.08M | -97.17M | 469.34M |
| Total cash from financing activities | 122.99M | -941.42M | -337.30M | -222.07M | 363.03M |
| Change to operating activities | - | - | - | -0.86M | 3.47M |
| Net income | 70.51M | 267.30M | 334.76M | 110.04M | 86.78M |
| Change in cash | 353.40M | 15.28M | 42.19M | -2.15M | 7.36M |
| Begin period cash flow | 184.31M | 169.02M | 126.83M | 9.88M | 2.52M |
| End period cash flow | 537.70M | 184.31M | 169.02M | 7.73M | 9.88M |
| Total cash from operating activities | 1280.46M | 1070.50M | 956.24M | 258.40M | 247.56M |
| Issuance of capital stock | 1.15M | 0.32M | 0.28M | 106.02M | 268.13M |
| Depreciation | 1058.87M | 1057.20M | 749.90M | 189.64M | 157.87M |
| Other cashflows from investing activities | 20.04M | 1.36M | -488.36M | 105.97M | 79.64M |
| Dividends paid | 849.10M | 794.78M | 657.02M | -209.42M | -198.84M |
| Change to inventory | - | - | 104.51M | - | - |
| Change to account receivables | -16.27M | -40.86M | -21.57M | -7.65M | -2.86M |
| Sale purchase of stock | -97.14M | -190.69M | -6.52M | -6.74M | -157.44M |
| Other cashflows from financing activities | -40.60M | -109.48M | -52.12M | 279.16M | 1325.05M |
| Change to netincome | - | - | - | -39.71M | -8.33M |
| Capital expenditures | 133.95M | 115.78M | 113.60M | 39.87M | 32.57M |
| Change receivables | - | - | - | -7.65M | -2.86M |
| Cash flows other operating | - | - | - | 4.58M | 12.89M |
| Cash and cash equivalents changes | - | - | - | -2.15M | 7.36M |
| Change in working capital | 105.75M | 44.77M | 82.94M | -10.77M | 0.26M |
| Stock based compensation | 14.41M | 31.77M | 14.48M | 15.67M | 15.03M |
| Other non cash items | 45.34M | -328.86M | -211.24M | -46.18M | -0.26M |
| Free cash flow | 1146.51M | 1070.50M | 956.24M | 218.53M | 214.99M |
Sector: Real Estate Industry: REIT - Healthcare Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| DOC Healthpeak Properties Inc |
-0.03 0.12% |
20.14 | 164.70 | 113.64 | 4.06 | 1.58 | 7.64 | 13.08 |
| WELL Welltower Inc |
-2.06 0.83% |
245.93 | 170.68 | 72.46 | 7.75 | 2.13 | 9.77 | 27.67 |
| VTR Ventas Inc |
-0.06 0.06% |
89.14 | 161.02 | 131.58 | 7.08 | 3.12 | 9.07 | 24.46 |
| OHI Omega Healthcare Investors Inc |
-0.95 1.94% |
48.22 | 16.83 | 10.13 | 11.78 | 2.66 | 14.30 | 12.72 |
| AHR American Healthcare REIT, Inc. |
-0.54 0.96% |
55.83 | 117.90 | 61.73 | 4.21 | 2.90 | 4.96 | 31.16 |
Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. Our company was originally founded in 1985. We are organized as an umbrella partnership REIT. We hold substantially all our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and continuing care retirement community real estate. Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the CCRC segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) an interest in an unconsolidated joint venture that owns 19 senior housing assets, (ii) loans receivable, and (iii) a preferred equity investment. These non-reportable segments have been presented on a combined basis herein. At September 30, 2025, our portfolio of investments, including properties in certain of our unconsolidated joint ventures, consisted of interests in 703 properties: (i) Outpatient medical " 530 properties; (ii) Lab " 139 properties; (iii) CCRC " 15 properties; and (iv) Other non-reportable " 19 properties. Healthpeak Properties, Inc. was incorporated in 1985 in Maryland, USA.
4600 South Syracuse Street, Denver, CO, United States, 80237
(720) 428-5050
411
| Name | Title | Year Born |
|---|---|---|
| Mr. John T. Thomas | Pres, CEO & Trustee | 1966 |
| Mr. Jeffrey Nelson Theiler | Exec. VP, CFO & Head of Investor Relations | 1974 |
| Mr. Del Mar Deeni Taylor | Exec. VP & Chief Investment Officer | 1957 |
| Mr. John W. Lucey | Chief Accounting & Admin. Officer | 1962 |
| Mr. Mark D. Theine | Exec. VP of Asset Management | 1983 |
| Mr. Bradley D. Page J.D. | Sr. VP & Gen. Counsel | 1961 |
| Mr. Daniel M. Klein J.D. | Sr. VP & Deputy Chief Investment Officer | 1965 |
| Mr. W. Mark Dukes C.C.I.M. | Sr. VP of Asset Management | 1963 |
| Ms. Amy M. Hall | Sr. VP of Leasing & Physician Strategy | 1983 |
| Ms. Laurie P. Becker | Sr. VP & Controller | 1980 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.